TotalMarketCap

Traws Pharma

TRAWNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.381 M

$0.22 -18.52%

Close of 6 Nov 2026

As of 6 Nov 2026, Traws Pharma (TRAW) has a market capitalization of $3.38M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.79M

#3360 by revenue

Earnings

$9.17M

#2046 by earnings

Shares outstanding

15,368,277

Latest filing cover page

P/E ratio

0.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #464GRI BioGRI$3.45M
  2. #465Medicus PharmaMDCX$3.45M
  3. #466Traws PharmaTRAW$3.38M
  4. #467Aptevo TherapeuticsAPVO$3.30M
  5. #468OnconetixONCO$3.27M

What if Traws Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,837,348

Per share 8,351,582× higher

Bitcoin $1.53T

$99,415.70

Per share 451,890× higher

Apple $5.02T

$326,372.47

Per share 1,483,511× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Traws Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.